ORHEO: Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Sponsor
Hospira, now a wholly owned subsidiary of Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT02140736
Collaborator
(none)
2,333
188
23
12.4
0.5

Study Details

Study Description

Brief Summary

The main aim of this study is to observe correction of the hemoglobin level in the patients under chemotherapy, treated with epoetin alfa biosimilar and presenting with a solid tumor or a lymphoma or a myeloma.

Condition or Disease Intervention/Treatment Phase
  • Drug: Epoetin biosimilar

Detailed Description

This is a non-interventional, descriptive, national, multi-site, longitudinal and prospective observational study with adults patients who are suffering from cancer or malignant blood disease and whose chemotherapy treatment has induced symptomatic anemia and being treated with biosimilar of epoetin to correct haemoglobin levels.

Study Design

Study Type:
Observational
Actual Enrollment :
2333 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study
Study Start Date :
Sep 1, 2009
Actual Primary Completion Date :
Aug 1, 2011
Actual Study Completion Date :
Aug 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Patients with chemo-induced symptomatic anemia

Drug: Epoetin biosimilar

Outcome Measures

Primary Outcome Measures

  1. Change and corrected Hemoglobin levels [6 months]

    Participants who have hemoglobin values between 11 and 12 g/dl after 6 months of treatment.

Secondary Outcome Measures

  1. Observe evolution of the biological indicators [6 months]

    Observe evolution of the biological indicators: hemoglobin, hematocrit, reticulocytes, serum iron, ferritin, transferrin saturation

  2. Study the profiles of treated patients [6 months]

  3. Assess the reasons for the prescriber's treatment regimens [6 months]

  4. Assess the correlations between the prescribing oncologists' treatment regimens and the patient characteristics [6 months]

  5. Observation of the safety profiles of the Product (Epoetin Alfa) [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients of more than 18 years of age

  • Patients presenting with anemia following chemotherapy

  • Patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy

-- The patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)

  • Patients eligible for epoetin alfa biosimilar treatment
Exclusion Criteria:
  • Patients are not receiving chemotherapy

  • Patients already included in an epoetin zeta trial

  • Patients presenting with a contraindication to epoetin zeta

  • Patients presenting with hypersensitivity to the active principle or any of the excipients

  • Patient with erythroblastopenia or acquired pure red cell aplasia (APRCA)

  • Patient with uncontrollable arterial hypertension

  • Patients who cannot receive adequate prophylaxis by antithrombotic agents

Contacts and Locations

Locations

Site City State Country Postal Code
1 Agen France 47000
2 Aix En Provence Cedex France 13616
3 Aix En Provence France 13100
4 Aix En Provence France 13101
5 Aix En Provence France 13616
6 Ajaccio Cedex France 20176
7 Albi France 81000
8 Amboise France 37400
9 Amilly France 45200
10 Annecy France 74000
11 Antibes France 6606
12 Armentieres France 59421
13 Arras Cedex France 62022
14 Arras France 62000
15 AULNAY SOUS BOIS Cedex France 93602
16 Avignon Cedex 2 France 84082
17 Avignon France 84000
18 Bayonne France 64100
19 Beauvais France 60021
20 Besancon Cedex France 25030
21 Besancon France 25030
22 Bethune France 62400
23 Beuvry France 62660
24 Beziers France 34500
25 Blois France 41000
26 Bois-guillaume France 76230
27 Bordeaux Cedex France 33076
28 Bordeaux France 33000
29 Bordeaux France 33300
30 Boulogne Sur Mer France 62200
31 Brest Cedex France 29609
32 Brest France 29200
33 Brest France 29609
34 Bron France 69500
35 Caen France 14000
36 Caen France 14033
37 Cannes France 6401
38 Cannes France 6414
39 Carcassonne Cedex 9 France 11890
40 Carcassonne France 11000
41 Castelnau Le Lez France 34170
42 Challes Les Eaux France 73190
43 Chalon/saonne France 71321
44 Chambery Cedex France 73011
45 Chambery France 73000
46 Chambery France 73011
47 Cherbourg-octeville France 50100
48 Clermont Ferrand Cedex 1 France 63011
49 Colmar Cedex France 68024
50 Colmar France 68000
51 Colmar France 68024
52 Compiegne France 60321
53 Creteil France 94000
54 Croix Cedex France 59963
55 Croix France 59963
56 Desertines France 3630
57 Dijon Cedex France 21079
58 Draguignan Cedex France 83007
59 Draguignan Cedex France 83300
60 Draguignan France 83007
61 Dunkerque France 59240
62 Evreux France 27025
63 Feurs France 42110
64 Foix Cedex France 9017
65 Frejus Cedex France 83608
66 Frejus France 83600
67 Frejus France 83608
68 Freyming Merlebach France 57804
69 Fryming Merle Bach France 57800
70 Gap Cedex France 5007
71 GAP France 5000
72 Grasse France 6135
73 Haguenau France 67500
74 Hyeres France 83056
75 Hyeres France 83400
76 La Roche Sur Yon Cedex 9 France 85925
77 La Rochelle Cedex 1 France 17019
78 La Seyne Sur Mer France 83500
79 La Tronche France 38700
80 Le Blanc Mesnil France 93150
81 Le Mans Cedex 9 France 72037
82 Lille Cedex France 59000
83 Lille France 59000
84 Lille France 59037
85 Limoges Cedex France 87042
86 Lyon Cedex 07 France 69365
87 Lyon Cedex 8 France 69373
88 Lyon France 69000
89 Lyon France 69424
90 Lyon France 69437
91 Macon Cedex France 71018
92 Mareuil Les Maux France 77100
93 Marseille Cedex 08 France 13285
94 Marseille Cedex 20 France 13915
95 Marseille France 13004
96 Marseille France 13005
97 Marseille France 13006
98 Marseille France 13008
99 Marseille France 13009
100 Marseille France 13012
101 Marseille France 13015
102 Marseille France 13385
103 Meaux France 77100
104 Metz Cedex 01 France 57038
105 Metz Cedex 3 France 57077
106 Monaco France 98012
107 Mont de Marsan France 40024
108 Montargis Cedex France 45207
109 Montauban France 82013
110 Montbeliard France 25200
111 Montbeliard France 25209
112 Montfermeil France 93370
113 Montpellier Cedex 5 France 34295
114 Montpellier France 34090
115 Montpellier France 34295
116 Morlaix France 29600
117 Moulins France 3006
118 Mulhouse Cedex France 68067
119 Mulhouse Cedex France 68070
120 Mulhouse France 68051
121 Mulhouse France 68070
122 Nancy France 54100
123 Nantes St Herblain France 44805
124 Nantes France 44093
125 Narbonne France 11100
126 Nice Cedex 03 France 6202
127 Nice Cedex 2 France 6189
128 Nice France 6000
129 Nice France 6189
130 Nimes France 30900
131 Niort France 79021
132 Nogent/Marne France 94130
133 Nîmes Cedex France 30029
134 Orleans France 45067
135 Paris France 75004
136 Paris France 75007
137 Paris France 75014
138 Paris France 75018
139 Paris France 75116
140 Perpignan Cedex France 66046
141 Pessac France 33604
142 Pierre Benite Cedex France 69495
143 Poitiers France 86021
144 Pontoise France 95300
145 Pringy Cedex France 74374
146 Pringy France 74370
147 Reims France 51100
148 Rennes Cedex 9 France 35033
149 Rouen France 76000
150 Rouen France 76044
151 Rouen France 76100
152 Saint Cloud France 92210
153 Saint Gaudens France 31800
154 Saint Germain En Laye France 78015
155 Saint Quentin France 02321
156 Sainte Feyre France 23000
157 Selestat France 67604
158 St Cloud France 92210
159 St Germain En Laye France 78100
160 St Germain France 78100
161 St HERBLAIN CEDEX France 44805
162 St Priest En Jarez Cedex France 42227
163 Strasbourg Cedex 2 France 67098
164 Strasbourg Cedex France 67065
165 Strasbourg Cedex France 67091
166 Strasbourg France 67000
167 Strasbourg France 67098
168 Strasbourg France 67100
169 Talence Cedex France 33401
170 Talence France 33401
171 Tarbes France 65000
172 Thionville France 57100
173 Thonon-les-bains France 74203
174 Toulon Cedex 9 France 83041
175 Toulon France 83056
176 Toulon France 83100
177 Toulouse Cedex 9 France 31059
178 Toulouse France 31076
179 Tours Cedex 9 France 37044
180 Tremblay En France France 93290
181 Troyes France 10003
182 Valence Cedex France 26953
183 Vandoeuvre Les Nancy France 54511
184 Venissieux France 69200
185 Versailles France 78000
186 Vichy France 3201
187 Villefranche/saone France 69655
188 Villeneuve Sur Lot France 47307

Sponsors and Collaborators

  • Hospira, now a wholly owned subsidiary of Pfizer

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospira, now a wholly owned subsidiary of Pfizer
ClinicalTrials.gov Identifier:
NCT02140736
Other Study ID Numbers:
  • 1_09.04.2009
  • 09.214
First Posted:
May 16, 2014
Last Update Posted:
Mar 20, 2017
Last Verified:
Jul 1, 2015
Keywords provided by Hospira, now a wholly owned subsidiary of Pfizer
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 20, 2017